Anti-GLP-1(7-37) and GLP-1(7-36)amide (N-terminal specific)

Cat.No. ABS 033-10B

Cat. No.
ABS 033-10B
Product name
Anti-GLP-1(7-37) and GLP-1(7-36)amide (N-terminal specific)

Mouse monoclonal antibody, biotinylated


ABS 033-10 binds the free N-terminus of GLP-1(7-37) and GLP-1(7-36)amide and shows <0.2% cross-reactivity with GLP-1(9-36)amide, glucagon and human GIP. Cross-reacts 0.25% with GLP-1(1-37), approximately 6% with human GLP-2 and approximately 50% with exendin-4. ABS 033-10 cross-reacts with Liraglutide. 


Synthetic GLP-1(7-17) 

Species reactivity (positive)
Species reactivity (negative)
Not determined


Gene ID
Clone number

Free N-terminus of GLP-1(7-37) and GLP-1(7-36)amide.


50 µL, 1 mg/mL +/- 15%. See Certificate of Analysis for details.

0.01 M phosphate buffer, pH 7.4, with 0.14 M NaCl and 15 mM sodium azide
4-8ºC without exposure to light. No precautions necessary during handling.

Glucagon-like peptide 1(7-36)amide (GLP-1(7-36)amide) is the principal active form of GLP-1, the other being GLP-1(7-37). GLP-1 is a peptide hormone of the glucagon family, produced by the L cells of the intestinal mucosa from the same prohormone as glucagon. The active forms are potent stimulators of glucose-dependent insulin secretion. The sequence of GLP-1 is fully conserved in all mammalian species examined so far.

Application 1


ABS 033-10B can be used as a detection antibody in combination with ABS 046-03 as a capture antibody in order to measure non-amidated GLP-1 forms and cross-reacting about 5% with C-terminally amidated GLP-1. Results show detection limits of 44pmol/L which is 10-20 times higher than the basal concentration of GLP-1, so the assays have to be optimized. 
This uses HYB 147-06 as capture antibody in combination with biotinylated detection antibody ABS 033-10 exclusively to measure GLP-1(7-36)amide in biological samples. GLP-1(7-36)amide is the principal active form of the peptide, and has been estimated to make up about 70% of the physiological response. Relative to measuring both active forms of GLP-1 together, the responses are reduced by not measuring the approximately 30% contribution of GLP-1(7-37) to the overall response. There is no cross-reactivity with any extended or truncated physiological form of GLP-1(7-36)amide. Specimens must be collected into tubes containing an adequate amount of DPP-4 inhibitor (in addition to routine peptidase inhibitors) to prevent the rapid in vitro degradation of the active peptide.
The calibration curve of a sandwich assay for Non-amidated GLP-1 using ABS 046-03 as the capture antibody and ABS 033-10B as the biotinylated detection antibody.